Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Remdesivir and Convalescent Plasma Therapy for Treatment of COVID-19 Infection in Nepal : A Registry Study

NCT04669990 is registered in ClinicalTrials.gov with Nepal Health Research Council as lead sponsor.

NCT NCT04669990
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04669990 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Remdesivir and Convalescent Plasma Therapy for Treatment of COVID-19 Infection in Nepal : A Registry Study
Lead sponsor
Nepal Health Research Council
Phase
Observational
Overall status
Unknown status
Start date
November 19, 2020
Completion date
November 19, 2021
Enrollment
2,000 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

covid19